Laurence Rozen

1.0k total citations
40 papers, 647 citations indexed

About

Laurence Rozen is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Laurence Rozen has authored 40 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 15 papers in Genetics and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Laurence Rozen's work include Hemoglobinopathies and Related Disorders (13 papers), Iron Metabolism and Disorders (9 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Laurence Rozen is often cited by papers focused on Hemoglobinopathies and Related Disorders (13 papers), Iron Metabolism and Disorders (9 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Laurence Rozen collaborates with scholars based in Belgium, United States and Australia. Laurence Rozen's co-authors include Alina Ferster, Anne Demulder, France Debaugnies, Phu-Quoc Lê, Francis Corazza, Sophie Huybrechts, Laurence Dedeken, Cathérine Heijmans, Christine Devalck and Nathalie Meuleman and has published in prestigious journals such as Blood, PLoS ONE and British Journal of Haematology.

In The Last Decade

Laurence Rozen

38 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurence Rozen Belgium 13 432 303 148 116 89 40 647
Deniz Aslan Türkiye 14 338 0.8× 132 0.4× 84 0.6× 50 0.4× 74 0.8× 50 707
D Rafanelli Italy 18 376 0.9× 141 0.5× 65 0.4× 92 0.8× 56 0.6× 47 734
Ben Saxon Australia 12 356 0.8× 184 0.6× 39 0.3× 86 0.7× 38 0.4× 37 690
Phu-Quoc Lê Belgium 17 461 1.1× 412 1.4× 41 0.3× 206 1.8× 42 0.5× 45 738
Selin Aytaç Türkiye 15 232 0.5× 59 0.2× 64 0.4× 84 0.7× 95 1.1× 63 553
Trisha E. Wong United States 14 530 1.2× 457 1.5× 33 0.2× 123 1.1× 59 0.7× 27 851
Ulrik Sprogøe Denmark 13 251 0.6× 60 0.2× 159 1.1× 177 1.5× 38 0.4× 35 559
Joerg Halter Switzerland 15 483 1.1× 61 0.2× 78 0.5× 81 0.7× 123 1.4× 40 742
Hamayun Imran United States 9 216 0.5× 106 0.3× 103 0.7× 38 0.3× 60 0.7× 25 389
G. D. Poole United Kingdom 11 472 1.1× 138 0.5× 50 0.3× 95 0.8× 79 0.9× 19 783

Countries citing papers authored by Laurence Rozen

Since Specialization
Citations

This map shows the geographic impact of Laurence Rozen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Rozen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Rozen more than expected).

Fields of papers citing papers by Laurence Rozen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Rozen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Rozen. The network helps show where Laurence Rozen may publish in the future.

Co-authorship network of co-authors of Laurence Rozen

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Rozen. A scholar is included among the top collaborators of Laurence Rozen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Rozen. Laurence Rozen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Besse‐Hammer, Tatiana, et al.. (2025). Exploring Hypercoagulability in Post-COVID Syndrome (PCS): An Attempt at Unraveling the Endothelial Dysfunction. Journal of Clinical Medicine. 14(3). 789–789. 1 indexed citations
2.
Demulder, Anne, et al.. (2022). Global Hemostasis Potential in COVID-19 Positive Patients Performed on St-Genesia Show Hypercoagulable State. Journal of Clinical Medicine. 11(24). 7255–7255. 3 indexed citations
3.
Demulder, Anne, et al.. (2021). Macrothrombocytopenia and stomatocytosis in sitosterolaemia. British Journal of Haematology. 194(5). 804–804. 1 indexed citations
4.
Rozen, Laurence, Denis F. Noubouossie, Laurence Dedeken, et al.. (2019). Is There Any Improvement of the Coagulation Imbalance in Sickle Cell Disease after Hematopoietic Stem Cell Transplantation?. Journal of Clinical Medicine. 8(11). 1796–1796. 2 indexed citations
5.
Willems, Ariane, David Faraoni, A. De Villé, et al.. (2016). Heparin Reversal After Cardiopulmonary Bypass: Are Point-of-Care Coagulation Tests Interchangeable?. Journal of Cardiothoracic and Vascular Anesthesia. 30(5). 1184–1189. 7 indexed citations
6.
Debaugnies, France, Bhavna Mahadeb, Alina Ferster, et al.. (2016). Performances of the H-Score for Diagnosis of Hemophagocytic Lymphohistiocytosis in Adult and Pediatric Patients. American Journal of Clinical Pathology. 145(6). 862–870. 143 indexed citations
7.
Nagant, Carole, et al.. (2016). HIL Interferences on Three Hemostasis Analyzers and Contribution of a Preanalytical Module for Routine Coagulation Assays. Clinical Laboratory. 62(10/2016). 1979–1987. 23 indexed citations
8.
Lê, Phu-Quoc, Béatrice Gulbis, Laurence Dedeken, et al.. (2015). Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. Pediatric Blood & Cancer. 62(11). 1956–1961. 122 indexed citations
9.
Sculier, Jean‐Paul, et al.. (2015). Medical anticancer treatment of lung cancer associated with comorbidities: A review. Lung Cancer. 87(3). 241–248. 8 indexed citations
10.
Rozen, Laurence, David Faraoni, Cristel Sanchez Torres, et al.. (2015). Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease. European Journal of Anaesthesiology. 32(12). 844–850. 17 indexed citations
11.
Dedeken, Laurence, Phu-Quoc Lê, Cathérine Heijmans, et al.. (2014). Reduction of the Six-Minute Walk Distance in Children with Sickle Cell Disease Is Correlated with Silent Infarct: Results from a Cross-Sectional Evaluation in a Single Center in Belgium. PLoS ONE. 9(10). e108922–e108922. 12 indexed citations
12.
Faraoni, David, Laurence Rozen, Ariane Willems, et al.. (2014). Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease. Blood Coagulation & Fibrinolysis. 26(3). 290–297. 14 indexed citations
13.
Rozen, Laurence, Sophie Huybrechts, Laurence Dedeken, et al.. (2013). Transient leukemia in a newborn without Down syndrome: case report and review of the literature. European Journal of Pediatrics. 173(12). 1643–1647. 11 indexed citations
14.
Morissens, Marielle, et al.. (2012). Loiasis with Pleural and Peritoneal Involvement. Journal of Travel Medicine. 19(3). 186–188. 3 indexed citations
15.
Noubouossie, Denis F., Phu-Quoc Lê, Francis Corazza, et al.. (2011). Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children. American Journal of Hematology. 87(2). 145–149. 32 indexed citations
16.
Quentin, Christine, Sophie Huybrechts, Laurence Rozen, et al.. (2011). Vitamin B12 deficiency in a 9-month-old boy. European Journal of Pediatrics. 171(1). 193–195. 18 indexed citations
17.
18.
Debaugnies, France, Denis F. Noubouossie, Laurence Rozen, et al.. (2010). Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay. Thrombosis Research. 126(6). 531–535. 22 indexed citations
19.
LaBrooy, J T, et al.. (1994). A comparison of hepatitis C virus (HCV) RNA and – antibody as markers of infection and predictors of infectivity. Australian and New Zealand Journal of Medicine. 24(2). 182–187. 9 indexed citations
20.
Shaw, David, et al.. (1993). Chronic liver disease in asymptomatic hepatitis C antibody positive blood donors. Australian and New Zealand Journal of Medicine. 23(2). 176–180. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deniz Aslan Breakdown of academic impact, for papers by D Rafanelli Breakdown of academic impact, for papers by Ben Saxon Breakdown of academic impact, for papers by Phu-Quoc Lê Breakdown of academic impact, for papers by Selin Aytaç Breakdown of academic impact, for papers by Trisha E. Wong Breakdown of academic impact, for papers by Ulrik Sprogøe Breakdown of academic impact, for papers by Joerg Halter Breakdown of academic impact, for papers by Hamayun Imran Breakdown of academic impact, for papers by G. D. Poole
Rankless by CCL
2026